New Infectious Disease Dosage Forms
Shingrix (zoster vaccine recombinant)
New adjuvanted herpes zoster (shingles) vaccine approved in adults aged 50 years or older. Provides a strong and long-lasting immune response to help overcome the decline in immunity as people age.
Heplisav-B (hepatitis B vaccine)
New 2-dose series that is administered at 0 and 1 month.
Medscape © 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. FDA New Drug and Biologic Approvals -- 2017 Year-in-Review - Medscape - Jan 11, 2018.